JPH0152027B2 - - Google Patents
Info
- Publication number
- JPH0152027B2 JPH0152027B2 JP56167047A JP16704781A JPH0152027B2 JP H0152027 B2 JPH0152027 B2 JP H0152027B2 JP 56167047 A JP56167047 A JP 56167047A JP 16704781 A JP16704781 A JP 16704781A JP H0152027 B2 JPH0152027 B2 JP H0152027B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- adsorbent
- polyvalent
- groups
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000006243 chemical reaction Methods 0.000 claims description 39
- 239000003463 adsorbent Substances 0.000 claims description 36
- 150000001875 compounds Chemical class 0.000 claims description 17
- 239000004593 Epoxy Substances 0.000 claims description 15
- -1 amine compound Chemical class 0.000 claims description 15
- 125000003277 amino group Chemical group 0.000 claims description 12
- 238000004132 cross linking Methods 0.000 claims description 12
- 125000003700 epoxy group Chemical group 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 12
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 11
- 239000012736 aqueous medium Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 239000006185 dispersion Substances 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 6
- 239000003381 stabilizer Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 32
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 19
- 229960004657 indocyanine green Drugs 0.000 description 19
- 238000001179 sorption measurement Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 15
- GHAFORRTMVIXHS-UHFFFAOYSA-L bromosulfophthalein sodium Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(O)=CC=C1C1(C=2C=C(C(O)=CC=2)S([O-])(=O)=O)C(C(Br)=C(Br)C(Br)=C2Br)=C2C(=O)O1 GHAFORRTMVIXHS-UHFFFAOYSA-L 0.000 description 13
- 229960001734 sulfobromophthalein Drugs 0.000 description 13
- 239000000126 substance Substances 0.000 description 12
- 102000009027 Albumins Human genes 0.000 description 11
- 108010088751 Albumins Proteins 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- OUPZKGBUJRBPGC-UHFFFAOYSA-N 1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound O=C1N(CC2OC2)C(=O)N(CC2OC2)C(=O)N1CC1CO1 OUPZKGBUJRBPGC-UHFFFAOYSA-N 0.000 description 6
- 239000012888 bovine serum Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000012798 spherical particle Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 4
- 239000000440 bentonite Substances 0.000 description 4
- 229910000278 bentonite Inorganic materials 0.000 description 4
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 4
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 4
- 239000002612 dispersion medium Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 3
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 206010019663 Hepatic failure Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000008081 blood perfusion Effects 0.000 description 3
- 208000007903 liver failure Diseases 0.000 description 3
- 231100000835 liver failure Toxicity 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- LCFVJGUPQDGYKZ-UHFFFAOYSA-N Bisphenol A diglycidyl ether Chemical compound C=1C=C(OCC2OC2)C=CC=1C(C)(C)C(C=C1)=CC=C1OCC1CO1 LCFVJGUPQDGYKZ-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- QVLAWKAXOMEXPM-UHFFFAOYSA-N 1,1,1,2-tetrachloroethane Chemical class ClCC(Cl)(Cl)Cl QVLAWKAXOMEXPM-UHFFFAOYSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical class CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical class CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- QECCQGLIYMMHCR-UHFFFAOYSA-N 2-({2,2-Bis[(2-oxiranylmethoxy)methyl]butoxy}methyl)oxirane Chemical compound C1OC1COCC(COCC1OC1)(CC)COCC1CO1 QECCQGLIYMMHCR-UHFFFAOYSA-N 0.000 description 1
- SYEWHONLFGZGLK-UHFFFAOYSA-N 2-[1,3-bis(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COCC(OCC1OC1)COCC1CO1 SYEWHONLFGZGLK-UHFFFAOYSA-N 0.000 description 1
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 1
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 1
- AGXAFZNONAXBOS-UHFFFAOYSA-N 2-[[3-(oxiran-2-ylmethyl)phenyl]methyl]oxirane Chemical compound C=1C=CC(CC2OC2)=CC=1CC1CO1 AGXAFZNONAXBOS-UHFFFAOYSA-N 0.000 description 1
- FSYPIGPPWAJCJG-UHFFFAOYSA-N 2-[[4-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane Chemical compound C1OC1COC(C=C1)=CC=C1OCC1CO1 FSYPIGPPWAJCJG-UHFFFAOYSA-N 0.000 description 1
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010075 Coma hepatic Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical class ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940106691 bisphenol a Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
- 229960000648 digitoxin Drugs 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- ZZTCPWRAHWXWCH-UHFFFAOYSA-N diphenylmethanediamine Chemical compound C=1C=CC=CC=1C(N)(N)C1=CC=CC=C1 ZZTCPWRAHWXWCH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000002265 electronic spectrum Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 201000001059 hepatic coma Diseases 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 229940078979 liver therapy drug Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 229940035722 triiodothyronine Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Epoxy Resins (AREA)
- External Artificial Organs (AREA)
Description
ãçºæã®è©³çްãªèª¬æã
æ¬çºæã¯èäžå
šæã¯çš®ã
ã®è¬ç©äžæ¯çã®æ£è
ã®
è¡æ¶²äžã«å€éã«ååšããã¢ã«ããã³çµåæ§ç©è³ªç
ã«å¯ŸããŠåžçèœãæããåžçå€ã®è£œé æ¹æ³ã«é¢ã
ããDETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing an adsorbent that has the ability to adsorb albumin-binding substances that are present in large amounts in the blood of patients suffering from liver failure or various drug addictions.
èäžå
šçã®éã«ã¯ãæ£è
ã®è¡æ¶²äžã«ä»£è¬ç°åžžç©
質ã®éãå¢å€§ããç
æ
ãé²è¡ãããšæè¬èæ§æç¡
ãèªçºããããã®ãããªèäžå
šã®æ²»çæ³ã®äžã€ãš
ããŠã掻æ§ççã®åžçå€ãçšããè¡æ¶²äœå€æœ
æµã«
ããè§£æ¯ãç®çãšããè£å©èçæ³ã詊ã¿ãããŠã
ããæç¡ããã®èŠéçã®å¹æãäžããŠããããã
ãæŽ»æ§çã¯ã¢ã«ããã³çµåæ§ç©è³ªã®åžçèœãäœ
ããæåœçãé«ããããšã¯äŸç¶ãšããŠå°é£ãªç¶æ³
ã«ããããŸããããªã«ãã³ã«ä»£è¡šãããã¢ã«ãã
ã³çµåæ§ç©è³ªã®é€å»ã«ã€ããŠãã¢ã«ããã³ãã¢ã¬
ããŒã¹çã®ç²åã«åºå®åããåžçå€çãç¥ãããŠ
ãããããã®ç²åã¯ã¢ã«ããã³ã®åºå®åéãå°ã
ããã¢ã«ããã³çµåæ§ç©è³ªã®åžçèœã¯å
åã§ã¯ãª
ããæŽã«é°ã€ãªã³äº€ææš¹èæã¯åçš®ã®åæåžçå€
çã®äœ¿çšã詊ã¿ãããŠããããããããã¢ã«ãã
ã³çµåæ§ç©è³ªã«å¯Ÿããåžçèœãäžå
åã§ãã€ãŠã
æªã å®çšã«äŸããã«ã¯å°ã€ãŠããªããåŸã€ãŠã¢ã«
ããã³çµåæ§ç©è³ªã«å¯Ÿããåžçå¹çã®é«ããæ°ã
ãåžçå€ã®éçºãæãŸããŠããã In cases of liver failure, etc., the amount of metabolically abnormal substances increases in the patient's blood, and as the disease progresses, so-called hepatic coma is induced. As a treatment for such liver failure, auxiliary liver therapy has been attempted to detoxify patients through extracorporeal blood perfusion using adsorbents such as activated charcoal, and has been shown to be effective in helping patients wake up from coma. . However, activated carbon has a low adsorption capacity for albumin-binding substances, and it remains difficult to increase the survival rate. In addition, adsorbents in which albumin is immobilized on particles such as agarose are known for removing albumin-binding substances such as bilirubin, but these particles have a small amount of albumin immobilized, and the albumin-binding substances The adsorption capacity of is not sufficient. Furthermore, attempts have been made to use anion exchange resins or various synthetic adsorbents, but these all have insufficient adsorption capacity for albumin-binding substances.
It has not yet been put into practical use. Therefore, it is desired to develop a new adsorbent with high adsorption efficiency for albumin-binding substances.
æ¬çºæè
ã¯ããã®ãããªã¢ã«ããã³çµåæ§ãæ
ããããªã«ãã³ã«ä»£è¡šãããè¡äžæå®³ç©è³ªãå¹ç
ããåžçé€å»ãåŸãåžçå€ãéçºãã¹ãéææ€èš
ãè¡ã€ãçµæãå€äŸ¡ã¢ãã³ååç©ãšå€äŸ¡ãšããã·
ååç©ãšããç¹å®æ¡ä»¶äžã«ãããŠæ°Žæ§åªäœäžã§æž
æ¿éåãããŠèª¿è£œããéåäœããè¡æ¶²äžã®ã¢ã«ã
ãã³çµåæ§ç©è³ªãå¹çããåžçé€å»ãåŸãããšã
èŠåºããæ¬çºæã«å°éãããã®ã§ããã The present inventor conducted extensive research to develop an adsorbent that can efficiently adsorb and remove harmful substances in the blood, such as bilirubin, which has albumin binding properties, and found that a polyvalent amine compound and a polyvalent epoxy The present invention was achieved by discovering that a polymer prepared by suspension polymerizing a compound in an aqueous medium under specific conditions can efficiently adsorb and remove albumin-binding substances in blood.
ããªãã¡ãæ¬çºæã¯ãå€äŸ¡ã¢ãã³ååç©ãšå€äŸ¡
ãšããã·ååç©ãšãæ°Žãšäžæ··åæ§ã®äžæŽ»æ§ææ©æº¶
åªäžã«ãããŠ30âæªæºã®æž©åºŠã§éä»å åå¿ãã
ããæ¬¡ãã§å¿
èŠã«å¿ããŠè©²å€äŸ¡ãšããã·ååç©ã
远å ããããšã«ãã€ãŠåå¿ã«äœ¿çšãã該å€äŸ¡ãšã
ãã·ååç©äžã®å
šãšããã·åºãåå¿ã«äœ¿çšãã該
å€äŸ¡ã¢ãã³ååç©äžã®ã¢ãã³åºåã³ã€ããåºã®ïŒ
åœéåœãåã¯è©²å€äŸ¡ã¢ãã³ååç©äžã«ã€ããåºã
å«ãŸãªãå Žåã«ã¯ã¢ãã³åºïŒåœéåœã1.05ã1.70
åœéã®ç¯å²ã«ãªãããã«èª¿ç¯ãã忣å®å®å€ãå«
æããæ°Žæ§åªäœäžã«æžæ¿åæ£ãããã30â以äžã®
æž©åºŠã§æŽã«åå¿ãè¡ãããšã«ãããæžæ¿ç²åãæ¶
æ©ç¡¬åããããããšãããªãåžçå€ã®è£œé æ¹æ³ã§
ããã That is, in the present invention, a polyvalent amine compound and a polyvalent epoxy compound are subjected to a polyaddition reaction in an inert organic solvent immiscible with water at a temperature of less than 30°C, and then, if necessary, the polyvalent epoxy compound is By adding, all the epoxy groups in the polyvalent epoxy compound used in the reaction are reduced to one of the amine groups and imino groups in the polyvalent amine compound used in the reaction.
1.05 to 1.70 per equivalent or per equivalent of amine group if the polyvalent amine compound does not contain an imino group
An adsorbent that consists of crosslinking and hardening the suspended particles by adjusting the weight to an equivalent range, suspending and dispersing them in an aqueous medium containing a dispersion stabilizer, and further reacting at a temperature of 30°C or higher. This is a manufacturing method.
æ¬çºæã説æããã The present invention will be explained.
æ¬çºæã®åžçå€ã®è£œé ã«å¿
èŠãªæåã§ããå€äŸ¡
ã¢ãã³ååç©ãšããŠã¯ã次ã®ãããªååç©ãéé
å®çãªäŸãšããŠæããããã Non-limiting examples of the polyvalent amine compound which is a necessary component for producing the adsorbent of the present invention include the following compounds.
H2NâïŒCH2âïŒoNH2.RâNHâïŒCH2CH2NH
âïŒnRâ².
ãäœããïœã¯ïŒã10ã®æŽæ°ãïœã¯ïŒã10000ã®æŽ
æ°ã衚ãããåã³Râ²ã¯ç¬ç«ã«æ°ŽçŽ åååã¯ç
çŽ ååæ°ïŒã20ã®ã¢ã«ãã«ãã¢ã«ã±ãã«ãã¢ãªãŒ
ã«ãã¢ã©ã«ãã«åã¯ã¢ã«ã«ããŒã«ã衚ãããã
çã H 2 Nâ(CH 2 â) o NH 2 .RâNHâ(CH 2 CH 2 NH
-) n R'. [However, n represents an integer of 1 to 10, m represents an integer of 1 to 10,000, and R and R' independently represent a hydrogen atom or alkyl, alkenyl, aryl, having 1 to 20 carbon atoms, Represents an aralkyl or alkanol. ] etc.
æ¬çºæã®åžçå€ã®è£œé ã«äœ¿çšãããå€äŸ¡ãšãã
ã·ååç©ãšããŠã¯ã次ã®ãããªç©è³ªãééå®çãª
äŸãšããŠæããããã Non-limiting examples of polyepoxy compounds used in the production of the adsorbent of the present invention include the following materials:
ãããã¯
ïŒäœããïœãïœãïœã¯ïŒã10ã®æŽæ°ã衚ãããïŒ
åã¯ã°ãªã»ããŒã«ãžã°ãªã·ãžã«ãšãŒãã«ãã°ãªã»
ããŒã«ããªã°ãªã·ãžã«ãšãŒãã«ãïŒïŒïŒïŒïŒâã
ãªã¡ãããŒã«ãããã³ããªã°ãªã·ãžã«ãšãŒãã«ã
ããªãã³ãã«ã°ãªã³ãŒã«ãžã°ãªã·ãžã«ãšãŒãã«ã
ãœã«ãããŒã«ããªã°ãªã·ãžã«ãšãŒãã«ããã€ãã
ããã³ãžã°ãªã·ãžã«ãšãŒãã«ãã¬ãŸã«ã·ã³ãžã°ãª
ã·ãžã«ãšãŒãã«ãããªã°ãªã·ãžã«ã€ãœã·ã¢ãã¬ãŒ
ãçã or (However, p, q, r represent integers from 1 to 10.)
or glycerol diglycidyl ether, glycerol triglycidyl ether, 1,1,1-trimethylolpropane triglycidyl ether,
Neopentyl glycol diglycidyl ether,
Sorbitol polyglycidyl ether, hydroquinone diglycidyl ether, resorcin diglycidyl ether, triglycidyl isocyanurate, etc.
æ¬çºæã®åžçå€ã®è£œé æ¹æ³ã¯ãå
ãå€äŸ¡ã¢ãã³
ååç©ãšå€äŸ¡ãšããã·ååç©ãšããæ°Žãšäžæ··åæ§
ã®äžæŽ»æ§ææ©æº¶åªäžã«ãããŠ30âæªæºã®æž©åºŠã§é
ä»å åå¿ããããæº¶åªæº¶è§£æ§ã®çŽéç¶ãã¬ããªã
ãŒã調補ããåŸãåå¿ã«äœ¿çšããå
šãšããã·åºé
ãåå¿æ··åäžã®ã¢ãã³åºåã³ïŒåã¯ã€ããåºã«å¯Ÿ
ããŠéå°ã«ãªãããã«èª¿ç¯ããæ¬¡ã«ããã忣å®
å®å€ã嫿ããæ°Žæ§åªäœäžã«æžæ¿åæ£ãããã30
â以äžã®æž©åºŠã«å ç±ããŠæ¶æ©ç¡¬åãããããšã«ã
ã€ãŠçç¶ç²åã補é ãããã®ã§ããã In the method for producing the adsorbent of the present invention, first, a polyvalent amine compound and a polyvalent epoxy compound are subjected to a polyaddition reaction in an inert organic solvent immiscible with water at a temperature of less than 30°C. After preparing the linear prepolymer, the total amount of epoxy groups used in the reaction is adjusted to be in excess of the amine groups and/or imino groups in the reaction mixture, and then this is mixed with a dispersion stabilizer. Suspension and dispersion in an aqueous medium of 30
Spherical particles are produced by crosslinking and curing by heating to a temperature of .degree. C. or higher.
ãã®éã30âæªæºã®æž©åºŠã§åå¿ãè¡ãªãç¬¬ïŒæ®µ
éã®äºåéåã«ãããŠã¯ãã¢ãã³åºåã³ïŒåã¯ã€
ããåºãšãšããã·åºã®éæ¯ã¯ããšããã·åºéå°ã§
ãã¢ãã³åºéå°ã§ããã©ã¡ãã§ãå·®ãéãã¯ãª
ãããã€ãšããã¬ããªããŒã®éå床ã¯é«ãæ¹ãåž
çå€ã®æ©æ¢°ç匷床ãé«ããªã€ãŠå¥œãŸããããšã
ããã¢ãã³åºãšãšããã·åºã®éæ¯ã¯çã¢ã«ä»è¿ã§
è¡ãã®ã奜ãŸãããåå¿è©Šè¬ã®ä»èŸŒéã¯ãæåã«
éå°ã®å€äŸ¡ãšããã·ååç©ãšå€äŸ¡ã¢ãã³ååç©ã®
å
šéãåå¿å®¹åšäžã«æ·»å ããŠåå¿ãè¡ãããšãã§
ããããŸããå
ãçã¢ã«ã®å€äŸ¡ãšããã·ååç©ãš
å€äŸ¡ã¢ãã³ååç©ãæ·»å ããŠåå¿ãããããšã«ã
ããéå床ãå
åäžæãããæ¬¡ãã§éå°éã®å€äŸ¡
ãšããã·ååç©ãåå¿æ··åç©ã«æ·»å ããŠãåå¿ã«
䜿çšããå
šãšããã·åºãåå¿æ··åç©äžã®ã¢ãã³åº
åã³ïŒåã¯ã€ããåºïŒåœéåœã1.05ã1.70åœéãš
ãªãããã«èª¿ç¯ããããšãã§ããã In this case, in the first stage prepolymerization in which the reaction is carried out at a temperature below 30°C, the quantitative ratio of amine groups and/or imino groups to epoxy groups can be either excessive epoxy groups or excessive amine groups. There isn't. Of course, it is preferable that the degree of polymerization of the prepolymer is higher, since this increases the mechanical strength of the adsorbent, and therefore it is preferable that the molar ratio of the amine groups to the epoxy groups is approximately equimolar. Regarding the amount of reaction reagents to be charged, the reaction can be carried out by first adding the entire amount of excess polyvalent epoxy compound and polyvalent amine compound into a reaction vessel. In addition, by first adding equimolar amounts of a polyvalent epoxy compound and a polyvalent amine compound and causing the reaction, the degree of polymerization is sufficiently increased, and then an excess amount of the polyvalent epoxy compound is added to the reaction mixture and used for the reaction. It is also possible to adjust the total amount of epoxy groups to be 1.05 to 1.70 equivalents per equivalent of amine and/or imino groups in the reaction mixture.
ãã®ããã«ããŠç¬¬äžæ®µéã®ãã¬ããªããŒèª¿è£œçš
ã®äºåéåãçµäºããæç¹ã§ããã¬ããªããŒæº¶æ¶²
ã忣å®å®å€çã嫿ããæ°Žæ§åªäœäžã«æžæ¿åæ£
ãããåŸãåå¿æž©åºŠã30â以äžã«äžæãããŠæžæ¿
ç²åãæ¶æ©ç¡¬åãããããšã«ãããçç¶åžçå€ç²
åãåŸãã When the first step of prepolymerization for prepolymer preparation is completed in this way, the prepolymer solution is suspended and dispersed in an aqueous medium containing a dispersion stabilizer, etc., and the reaction temperature is increased to 30°C or higher. Spherical adsorbent particles are obtained by raising and crosslinking and hardening the suspended particles.
æ¬çºæã®åžçå€ã®è£œé ã«ãããéä»å åå¿ãè¡
ãåå¿æž©åºŠã¯ãç¬¬ïŒæ®µéã®ãã¬ããªããŒèª¿è£œã®äº
åéåã®éã«ã¯30âæªæºã®æž©åºŠã§åå¿ãè¡ããã®
ã§ããã30âæªæºã®æž©åºŠã§ã¯ãšããã·åºãšã¢ãã³
åºïŒïŒçŽã¢ãã³åºïŒãšãåªå
çã«åå¿ãããšãã
ã·åºãšã€ããåºïŒïŒçŽã¢ãã³åºïŒãšã®åå¿ãæå¶
ãããã®ã§ãçŽéç¶ãã¬ããªããŒãéžæçã«çæ
ããæ¶æ©ç¡¬ååå¿ã«ã€ãªããåå²ç¶ãã¬ããªããŒ
ã®çæãæå¶ããããšãã§ããã The reaction temperature at which the polyaddition reaction is carried out in the production of the adsorbent of the present invention is such that the reaction is carried out at a temperature of less than 30°C during the preliminary polymerization for preparing the prepolymer in the first stage. At temperatures below 30°C, epoxy groups and amine groups (primary amine groups) react preferentially, and the reaction between epoxy groups and imino groups (secondary amine groups) is suppressed, so linear prepolymers is selectively produced, and the production of branched prepolymers that lead to crosslinking and curing reactions can be suppressed.
次ã«ãç¬¬ïŒæ®µéã®æ¶æ©ç¡¬ååå¿ã¯ããã¬ããªã
ãŒæº¶æ¶²ãæ°Žæ§åªäœäžã«æžæ¿åæ£ãããåŸã30â以
äžã®æž©åºŠã«äžæãããããšã«ããããã¬ããªããŒ
ã®äž»éäžã®ã€ããåºãšãšããã·åºãšã®åå¿ãèµ·ã€
ãŠæžæ¿ç²åãæ¶æ©ç¡¬åãããããšãã§ããããã®
æ¶æ©ç¡¬ååå¿ã¯30âã100âã®æž©åºŠç¯å²ã奜ãŸã
ãã¯40âã80âã®æž©åºŠãç¹ã«å¥œãŸããã¯45âã70
âã®æž©åºŠãã§åå¿ãè¡ãããšãã§ããã Next, in the second step, the crosslinking and curing reaction is carried out by suspending and dispersing the prepolymer solution in an aqueous medium, and then raising the temperature to 30°C or higher. A reaction can occur to crosslink and harden the suspended particles. This crosslinking curing reaction is carried out at a temperature range of 30°C to 100°C, preferably 40°C to 80°C, particularly preferably 45°C to 70°C.
The reaction can be carried out at a temperature of °C.
ãŸããåå¿ã«äœ¿çšããå
šãšããã·åºã¯åå¿æ··å
ç©äžã®ã¢ãã³åºåã³ïŒåã¯ã€ããåºïŒåœéåœã
1.05ã1.70åœéã®ç¯å²ã§ãããå
šãšããã·åºéã
ã¢ããåºåã³ïŒåã¯ã€ããåºïŒåœéåœã1.05åœé
æªæºã®å Žåãæ¶æ©éãå
åã§ãªãåžçå€ç²åã®ç¡¬
åãäžå
åã«ãªãã匷床ã®é«ãçç¶ç²åã¯åŸãã
ãªããéã«å
šãšããã·åºãã¢ãã³åºåã³ïŒåã¯ã€
ããåºïŒåœéåœã1.70åœéãè¶
ããå Žåã«ã¯æ¶æ©
éãå€éããŠã被åžçç©è³ªãåžçå€ç²åäžã«æ¡æ£
ããã®ã劚ããåžçå¹çãäœäžããŠå®çšæ§ããªã
ãªãã®ã§å¥œãŸãããªãã In addition, the total epoxy group used in the reaction is per equivalent of amine group and/or imino group in the reaction mixture.
It ranges from 1.05 to 1.70 equivalents. If the total amount of epoxy groups is less than 1.05 equivalents per equivalent of amino groups and/or imino groups, the amount of crosslinking will be insufficient and the curing of the adsorbent particles will be insufficient, making it impossible to obtain spherical particles with high strength. On the other hand, if the total amount of epoxy groups exceeds 1.70 equivalents per equivalent of amine group and/or imino group, the amount of crosslinking will be too large and will prevent the adsorbed substance from diffusing into the adsorbent particles, reducing the adsorption efficiency. This is not desirable because it becomes impractical.
æ¬çºæã®è£œé æ¹æ³ã«äœ¿çšãããæ°Žãšäžæ··åæ§ã®
äžæŽ»æ§ææ©æº¶åªã¯ä»»æã§ããããå€äŸ¡ã¢ãã³åå
ç©ãšå€äŸ¡ãšããã·ååç©ãšã®éä»å åå¿çæç©ã®
溶解æ§ãæããããšãå¿
èŠã§ããããã®ãããªæº¶
åªãšããŠãå¡©åã¡ãã¬ã³ãã¯ãããã«ã ããžã¯ã
ã«ãšã¿ã³é¡ãããªã¯ãã«ãšã¿ã³é¡ãããªã¯ãã«ãš
ãã¬ã³é¡ãããã©ã¯ãã«ãšã¿ã³é¡çã®ããã²ã³å
èèªæçåæ°ŽçŽ ãã¢ãã¯ãã«ãã³ãŒã³ããžã¯ãã«
ãã³ãŒã³çã®ããã²ã³åè³éŠæçåæ°ŽçŽ ããããµ
ã³ãããã¿ã³ããªã¯ã¿ã³ãã·ã¯ããããµã³çã®è
èªæçåæ°ŽçŽ ããã³ãŒã³ããã«ãšã³ããã·ã¬ã³é¡
çã®è³éŠæçåæ°ŽçŽ ãããã¯ãããã®æ··åç©ãé
éå®çã«æããããã The water-immiscible inert organic solvent used in the production method of the present invention is optional, but it is necessary that it has the ability to dissolve the polyaddition reaction product between the polyvalent amine compound and the polyvalent epoxy compound. be. Examples of such solvents include halogenated aliphatic hydrocarbons such as methylene chloride, chloroform, dichloroethanes, trichloroethanes, trichloroethylenes, and tetrachloroethanes; halogenated aromatic hydrocarbons such as monochlorobenzene and dichlorobenzene; Non-limiting examples include aliphatic hydrocarbons such as hexane, heptane, octane, and cyclohexane, aromatic hydrocarbons such as benzene, toluene, and xylenes, and mixtures thereof.
æŽã«ããã²ã³åçåæ°ŽçŽ é¡çã®æ¯èŒçã«æ¯éã®
倧ããæº¶åªãçšããå Žåã«ã¯ã忣åªã§ããæ°Žãš
ã®åæ£ãåæ»ã«è¡ãããã«ã忣åªäžã«å¡©åãã
ãªãŠã ãç¡«é
žãããªãŠã ããªã³é
žãããªãŠã çã®
ç¡æ©å¡©é¡ããïŒééïŒ
ã50ééïŒ
ã奜ãŸããã¯ïŒ
ééïŒ
ã20ééïŒ
ã®ç¯å²ã®éãæ·»å 溶解ãããã
ãšãæãŸããã Furthermore, when using a solvent with relatively high specific gravity such as halogenated hydrocarbons, sodium chloride, sodium sulfate, sodium phosphate, etc. are added to the dispersion medium to ensure smooth dispersion with water, which is the dispersion medium. of inorganic salts in an amount of 1% to 50% by weight, preferably 5% by weight.
It is desirable to add and dissolve amounts ranging from % to 20% by weight.
æ¬çºæã®è£œé æ¹æ³ã«ãããå€äŸ¡ã¢ãã³ååç©ãš
å€äŸ¡ãšããã·ååç©ãšã®éä»å åå¿ã«ããããªã
ãªããŒæº¶æ¶²ãæ°Žæ§åªäœäžã«æžæ¿åæ£ãããéã«çš
ãã忣å®å®å€ãšããŠã¯ãäŸãã°ãã³ããã€ãã
ã¿ã«ã¯ãç¡«é
žããªãŠã ãçé
žã«ã«ã·ãŠã ããã¯ã
ã³ããŒã©ãã³ãããªã¢ã¯ãªã«é
žãããªã¢ã¯ãªã«
é
žãããªããã«ã¢ã«ã³ãŒã«çãæããããã Examples of the dispersion stabilizer used when suspending and dispersing the prepolymer solution obtained by the polyaddition reaction of a polyvalent amine compound and a polyvalent epoxy compound in an aqueous medium in the production method of the present invention include bentonite,
Examples include talc, barium sulfate, calcium carbonate, pectin, gelatin, polyacrylic acid, polyacrylic acid, polyvinyl alcohol, and the like.
å€äŸ¡ã¢ãã³ååç©ãšå€äŸ¡ãšããã·ååç©ãšã®æ··
åç©ãããã¯ãããã®éä»å åå¿ã«ãããã¬ããª
ããŒã®ææ©æº¶åªäžã®æ¿åºŠã¯ïŒééïŒ
ã80ééïŒ
ã
奜ãŸããã¯ïŒééïŒ
ã60ééïŒ
ãç¹ã«å¥œãŸããã¯
10ééïŒ
ã50ééïŒ
ã®ç¯å²ã§ããã The concentration of a mixture of a polyvalent amine compound and a polyvalent epoxy compound or a prepolymer obtained by a polyaddition reaction of these in an organic solvent is 2% by weight to 80% by weight,
Preferably 5% to 60% by weight, particularly preferably
It ranges from 10% to 50% by weight.
ãŸãå€äŸ¡ã¢ãã³ååç©ãšå€äŸ¡ãšããã·ååç©ãš
ã®åå¿ã«ãããã¬ããªããŒæº¶æ¶²ãšãããæžæ¿åæ£
ãããæ°Žæ§åæ£åªãšã®å®¹ç©æ¯ãïŒïŒïŒã100ã奜
ãŸããã¯ïŒïŒ2.5ã50ãç¹ã«å¥œãŸããã¯ïŒïŒïŒã
10ã®ç¯å²ã§ããã The volume ratio of the prepolymer solution obtained by the reaction of the polyvalent amine compound and the polyvalent epoxy compound to the aqueous dispersion medium in which it is suspended and dispersed is 1:2 to 100, preferably 1:2.5 to 50, particularly preferably 1. :3ïœ
The range is 10.
ãã®ããã«ããŠéä»å éåäœã®çç¶ç²åãåŸã
ããããããçç¶ç²åã®ç²åŸã¯ãæ¹æé床çã«ã
ã€ãŠèª¿ç¯ãå¯èœã§ãã€ãŠãçŽåŸã0.1ãïŒmmïŒå¥œ
ãŸããã¯0.5ã1.5mmïŒã®ç¯å²ãšããããšãæãŸã
ãã In this way, spherical particles of polyaddition polymer are obtained. The particle size of these spherical particles can be adjusted by adjusting the stirring speed, etc., and is preferably in the range of 0.1 to 2 mm (preferably 0.5 to 1.5 mm) in diameter.
ãã¬ããªããŒæº¶æ¶²ã®ç²åºŠããã¬ããªããŒæº¶æ¶²ãš
忣åªãšã®éæ¯çã«ãã€ãŠãæ¹æã®æé©é床ã¯å€
ã€ãŠããããäžè¬ã«50ã1000r.p.m.奜ãŸããã¯
100ã500r.p.m.ç¹ã«å¥œãŸããã¯120ã300r.p.mã®
ç¯å²ãéžæãããšããã The optimum stirring speed varies depending on the viscosity of the prepolymer solution, the ratio of the prepolymer solution to the dispersion medium, etc., but is generally 50 to 1000 rpm, preferably
A range of 100 to 500 r.pm, particularly preferably 120 to 300 r.pm, is preferably selected.
æ¬çºæã®è£œé æ¹æ³ã«ãããŠã¯ããã¬ããªããŒã®
ææ©æº¶åªæº¶æ¶²äžã«ãžãªã¯ãã«ãã¿ã¬ãŒãããã©ã
ã€ã³çã®éåå€ãæ·»å ããããšã«ãã€ãŠåžçå€ã®
çç¶ç²åãããå€åæ§ã«ããããšãã§ããã In the production method of the present invention, the spherical particles of the adsorbent can be made more porous by adding a pore opening agent such as dioctyl phthalate or paraffin to the organic solvent solution of the prepolymer.
æ¬çºæã®æ¹æ³ã«ãã€ãŠè£œé ãããåžçå€ã®äœ¿çš
æ¹æ³ã¯ä»»æã§ããããåžçå€ç²åãã«ã©ã çã«å
å¡«ããè¡æ¶²æãã¯è¡æŒ¿çãæœ
æµãããæ¹æ³ã奜é©
ã«çšãããããç¹ã«ãè¡æ çã®åœ¢æãªãã«è¡æ¶²ã
çŽæ¥ã«åžçå€ã«æ¥è§ŠãããŠæœ
æµã§ããããšããæ¬
çºæã«ãã補é ãããåžçå€ã®å€§ããªç¹åŸŽã®äžã€
ã§ããã Although the adsorbent produced by the method of the present invention can be used in any manner, a method of filling the adsorbent particles into a column or the like and perfusing it with blood, plasma, etc. is preferably used. In particular, one of the major features of the adsorbent produced by the present invention is that blood can be brought into direct contact with the adsorbent and perfused without forming thrombus or the like.
æ¬çºæã«ãã補é ãããåžçå€ã¯ã掻æ§çåžç
æãã¯éæçã®æäœã§é€å»ãã«ããè¡æ¶²äžã«ãã
ã¢ã«ããã³çµåæ§ç©è³ªãäŸãã°ãµã€ããã·ã³ãã
ãªãšãŒããµã€ããã³ãããªã«ãã³ãå°¿é
žãèæ±
é
žãã°ã¢ããžã³ãã€ã³ããŒã«ååç©ãã¢ã»ãã«ã³
ãªã³ããã«ãããŒã«é
žããžã®ããã·ã³ããµãªãã«
é
žããã®ä»çš®ã
ã®è¬ç©çã®åžçå€ãšããŠæ¥µããŠæ
çšã§ããã The adsorbent produced according to the present invention can contain albumin-binding substances found in blood that are difficult to remove by operations such as activated carbon adsorption or dialysis, such as thyroxine, triiodothyronine, bilirubin, uric acid, bile acids, guanidine, and indole compounds. It is extremely useful as an adsorbent for acetylcholine, barbituric acid, digitoxin, salicylic acid, and various other drugs.
以äžã宿œäŸããããŠæ¬çºæã説æããããª
ãã宿œäŸäžã®ãïŒ
ãã¯ééåºæºã§ãããè¡æŒ¿äž
ã®ããªã«ãã³æ¿åºŠã¯EvelynâMolloyæ³ã«ãã€ãŠ
枬å®ããã The present invention will be explained below with reference to Examples. Note that "%" in the examples is based on weight, and the bilirubin concentration in plasma was measured by the Evelyn-Molloy method.
ãŸãã€ã³ãã·ã¢ãã³ã°ãªãŒã³ïŒICGïŒãããã¢
ã¹ã«ããã¿ã¬ã€ã³ïŒBSPïŒã®æ¿åºŠã¯é»åã¹ãã¯
ãã«ã®åžå匷床ã«ãã€ãŠæž¬å®ããã In addition, the concentrations of indocyanine green (ICG) and bromosulfophthalein (BSP) were measured by the absorption intensity of electronic spectra.
宿œäŸ ïŒ
æ¹ææ©ã枩床èšãåããïŒã®äžã€å£ãã©ã¹ã³
ã«ããã¹ããšããŒã«ââãžã°ãªã·ãžã«ãšãŒãã«
19.0gïŒ0.05ã¢ã«ïŒãã°ãªã»ããŒã«ãžã°ãªã·ãžã«ãš
ãŒãã«39.2gïŒ0.2ã¢ã«ïŒããããµã¡ãã¬ã³ãžã¢ãã³
32.4gïŒ0.28ã¢ã«ïŒã50mlã®ã¯ãããã«ã ã«æº¶è§£ã
ãŠå ããæŽã«éåå€ãšããŠãžãªã¯ãã«ãã¿ã¬ãŒã
20gãå ããŠãåå¿æž©åºŠ28âã§ïŒæéåå¿ããã
ããšã«ããããã¬ããªããŒæº¶æ¶²ãåŸããæ¬¡ã«ãã
ã«ããªã°ãªã·ãžã«ã€ãœã·ã¢ãã¬ãŒã10gãã¯ãã
ãã«ã 30mlã«æº¶è§£ãããæº¶æ¶²ãå ããŠåå¿æž©åºŠ28
âã§ïŒæéåå¿ãããåŸãå¡©åãããªãŠã 40gã
ãã³ããã€ã6gã嫿ããæ°Žæº¶æ¶²800mlãæ·»å ã
ãŠãæ¹æé床130r.p.mã§æžæ¿åæ£ããããExample 1 Bisphenol-A-diglycidyl ether was added to two three-necked flasks equipped with a stirrer and a thermometer.
19.0g (0.05mol), glycerol diglycidyl ether 39.2g (0.2mol), hexamethylene diamine
32.4g (0.28mol) was dissolved in 50ml of chloroform and added, and dioctyl phthalate was added as a pore opening agent.
A prepolymer solution is obtained by adding 20 g and reacting at a reaction temperature of 28° C. for 3 hours. Next, a solution of 10 g of triglycidyl isocyanurate dissolved in 30 ml of chloroform was added to this, and the reaction temperature was 28°C.
After reacting for 1 hour at °C, 40 g of sodium chloride,
Add 800 ml of an aqueous solution containing 6 g of bentonite and suspend and disperse at a stirring speed of 130 rpm.
次ã«åå¿æž©åºŠã50âã«äžæãããŠïŒæéåå¿ã
ããåŸãåå¿æž©åºŠã70âãŸã§åŸã
ã«äžæãããŠæº¶
åªã®ã¯ãããã«ã ãçå»ãããªããïŒæéåå¿ã
è¡ã€ããåå¿çµäºåŸãç圢éåäœãåé¢ããæŽã«
ã¡ã¿ããŒã«æœåºãæŽæµãæ°ŽæŽãè¡ãããšã«ããåž
çå€80gãåŸãã Next, the reaction temperature was raised to 50°C and the reaction was carried out for 1 hour, and then the reaction temperature was gradually raised to 70°C and the reaction was carried out for 2 hours while distilling off the solvent chloroform. After the reaction was completed, the spherical polymer was separated and further extracted with methanol, washed, and washed with water to obtain 80 g of adsorbent.
ãã®åžçå€ãPH7.4ã®ãªã³é
žç·©è¡æ¶²äžã«æµžæŒ¬åŠ
çããåŸãïŒmlãæ¡åããããªã«ãã³10mgïŒdlã
ã€ã³ãã·ã¢ãã³ã°ãªãŒã³ïŒICGïŒïŒmgïŒdlããã
ã¢ã¹ã«ããã¿ã¬ã€ã³ïŒBSPïŒïŒmgïŒdlã嫿ã
ãçè¡æž
20mläžã«æµžæŒ¬ããŠã37âã®æž©åºŠã§ïŒæé
æ¯çªããåŸãåžçå€ãåé¢ããŠãçè¡æž
äžã«æ®å
ããåæåã®æ¿åºŠã枬å®ããåžççãæ±ãããšã
ããããªã«ãã³ïŒïŒïŒ
ãICG41ïŒ
ãBSP48ïŒ
ã®å
åžççãåŸãããè¡æž
äžã®èçœçµåæ§ç©è³ªããã
åžçããŠããããšãèªãããããæŽã«ãã®åžçå€
20mlãã·ãªã³ãŒã³åŠçããã¬ã©ã¹è£œã«ã©ã ã«å
å¡«
ããé åéèã·ã€ã³ãæè¡ãæœããçŽ3.0Kgã®å®¶
å
ãçšããŠ20mlïŒåã®æµéã«ããè¡æ¶²äœå€æœ
æµã
ïŒæéè¡ãªã€ãåŸãè¿è¡ããŠåžçå€ã®ç¶æ
ã芳å¯
ããçµæãè¡æ çã®åœ¢æã¯å
šãèªãããããè¡æ¶²
é©åæ§ã¯è¯å¥œã§ãã€ãã After immersing this adsorbent in a phosphate buffer solution with a pH of 7.4, 2 ml was collected, and bilirubin was 10 mg/dl.
After soaking in 20 ml of bovine serum containing 1 mg/dl of indocyanine green (ICG) and 5 mg/dl of bromosulfophthalein (BSP) and shaking at a temperature of 37°C for 3 hours, the adsorbent was separated. When we measured the concentration of each component remaining in bovine serum and determined the adsorption rate, we obtained adsorption rates of 50% for bilirubin, 41% for ICG, and 48% for BSP. It was recognized that there was. Furthermore, this adsorbent
20 ml was packed into a silicone-treated glass column, and extracorporeal blood perfusion was performed for 3 hours at a flow rate of 20 ml/min using an approximately 3.0 kg domestic rabbit that had undergone carotid arteriovenous shunt surgery, and then the blood was returned. As a result of observing the state of the adsorbent, no formation of thrombi or the like was observed, and blood compatibility was good.
æ¯èŒäŸ ïŒ
åžçå€ãšããŠã»ã«ããŒã«è¢«èп޻æ§çåã³ã¢ã³ã
ãŒã©ã€ãXADâïŒïŒããŒã ã»ã¢ã³ãã»ããŒã¹ç€Ÿ
補ïŒãçšããŠã宿œäŸïŒãšåæ§ã®æ¹æ³ã§ãçè¡æž
äžã®ããªã«ãã³ãã€ã³ãã·ã¢ãã³ã°ãªãŒã³
ïŒICGïŒãããã¢ã¹ã«ããã¿ã¬ã€ã³ïŒBSPïŒã®æ¯çª
åžç詊éšãè¡ã€ãåŠãã»ã«ããŒã«è¢«èп޻æ§çã¯åž
ççã¯ããããïŒïŒ
ã§ãããã¢ã³ããŒã©ã€ã
XADâïŒã¯ããªã«ãã³30ïŒ
ãICG35ïŒ
ãBSP15
ïŒ
ã®ååžççã§ãã€ããComparative Example 1 Bilirubin, indocyanine green (ICG), In a shaking adsorption test of bromosulfophthalein (BSP), cellulose-coated activated carbon had an adsorption rate of 0%, and Amberlite
XAD-7 is bilirubin 30%, ICG 35%, BSP15
% of each adsorption rate.
宿œäŸ ïŒ
宿œäŸïŒãšåæ§ã®æ¹æ³ã§ãã°ãªã»ããŒã«ãžã°ãª
ã·ãžã«ãšãŒãã«ã®ä»£ãã«ãšãã¬ã³ã°ãªã³ãŒã«ãžã°
ãªã·ãžã«ãšãŒãã«34.8gãçšããä»ã¯å
šãŠåæ§ã«
ããŠçç¶éåäœç²åãããªãåžçå€ã補é ãããExample 2 An adsorbent made of spherical polymer particles was produced in the same manner as in Example 1, except that 34.8 g of ethylene glycol diglycidyl ether was used instead of glycerol diglycidyl ether, and all other conditions were the same.
ãã®åžçå€ïŒmlãæ¡åãã宿œäŸïŒãšåæ§ã®æ¹
æ³ã§ãçè¡æž
äžã®ããªã«ãã³ãã€ã³ãã·ã¢ãã³ã°
ãªãŒã³ïŒICGïŒãããã¢ã¹ã«ããã¿ã¬ã€ã³ïŒBSPïŒ
ã®æ¯çªåžç詊éšãè¡ã€ãåŠãããªã«ãã³60ïŒ
ã
ICG60ïŒ
ãBSP65ïŒ
ã®ååžççãåŸãããã Collect 2 ml of this adsorbent and use the same method as in Example 1 to detect bilirubin, indocyanine green (ICG), and promosulfophthalein (BSP) in bovine serum.
When a shaking adsorption test was conducted, bilirubin 60%,
Adsorption rates of ICG 60% and BSP 65% were obtained.
宿œäŸ ïŒ
宿œäŸïŒãšåæ§ã®æ¹æ³ã§ããã¹ããšããŒã«â
âãžã°ãªã·ãžã«ãšãŒãã«19.0gãïŒïŒïŒâãã¿ã³
ãžãªãŒã«ãžã°ãªã·ãžã«ãšãŒãã«40.4gãïŒïŒ4â²â
ãžã¢ãããžããšãã«ã¡ã¿ã³27.6gåã³ãããµã¡ã
ã¬ã³ãžã¢ãã³16.2gãã¯ãããã«ã 40mlãã·ã¯ã
ãããµã³20mlåã³ãžãªã¯ãã«ãã¿ã¬ãŒã20gã®å
åšäžã«ã28âã®æž©åºŠã§åå¿ãããŠãã¬ããªããŒæº¶
æ¶²ã調補ãããããå¡©åãããªãŠã 40gãçé
žã«
ã«ã·ãŠã 10gã嫿ããæ°Žæ§åªäœäžã«æžæ¿åæ£ã
ããåŸãããªã°ãªã·ãžã«ã€ãœã·ã¢ãã¬ãŒã10gã
ã¯ãããã«ã 20mlåã³ã·ã¯ããããµã³10mlãããª
ãæº¶æ¶²ãå ããŠ50ã70âã®æž©åºŠã§æ¶æ©ç¡¬ååå¿ã
è¡ããçç¶éåäœãããªãåžçå€90gãåŸããExample 3 In the same manner as in Example 1, bisphenol-A
-Diglycidyl ether 19.0g, 1,4-butanediol diglycidyl ether 40.4g, 4,4'-
A prepolymer solution was prepared by reacting 27.6 g of diaminodiphenylmethane and 16.2 g of hexamethylene diamine in the presence of 40 ml of chloroform, 20 ml of cyclohexane, and 20 g of dioctyl phthalate at a temperature of 28°C, and this was mixed with 40 g of sodium chloride and calcium carbonate. 10 g of triglycidyl isocyanurate after suspension dispersion in an aqueous medium containing 10 g of
A solution consisting of 20 ml of chloroform and 10 ml of cyclohexane was added, and a crosslinking and curing reaction was carried out at a temperature of 50 to 70°C to obtain 90 g of an adsorbent made of a spherical polymer.
ãã®åžçå€ïŒmlãæ¡åãã宿œäŸïŒãšåæ§ã®æ¹
æ³ã§ãçè¡æž
äžã®ããªã«ãã³ãã€ã³ãã·ã¢ãã³ã°
ãªãŒã³ïŒICGïŒãããã¢ã¹ã«ããã¿ã¬ã€ã³ïŒBSPïŒ
ã®æ¯çªåžç詊éšãè¡ã€ãåŠãããªã«ãã³75ïŒ
ã
ICG75ïŒ
ãBSP81ïŒ
ã®ååžççãåŸãããã Collect 2 ml of this adsorbent and use the same method as in Example 1 to detect bilirubin, indocyanine green (ICG), and promosulfophthalein (BSP) in bovine serum.
When a shaking adsorption test was conducted, bilirubin was 75%,
Adsorption rates of ICG 75% and BSP 81% were obtained.
宿œäŸ ïŒ
宿œäŸïŒãšåæ§ã®æ¹æ³ã§ããã¹ããšããŒã«â
âãžã°ãªã·ãžã«ãšãŒãã«19.0gããšãã¬ã³ã°ãªã³
ãŒã«ãžã°ãªã·ãžã«ãšãŒãã«34.8gãïŒïŒ4â²âãžã¢
ãããžããšãã«ã¡ã¿ã³27.6gåã³ãããµã¡ãã¬ã³
ãžã¢ãã³16.2gãã¯ãããã«ã 40mlåã³ãžãªã¯ã
ã«ãã¿ã¬ãŒã20gã®ååšäžã«ã28âã®æž©åºŠã§åå¿
ãããŠããªããªããŒæº¶æ¶²ã調補ãããããå¡©åã
ããªãŠã 40gããã³ããã€ã6.0gã嫿ããæ°Žæ§
åªäœ800mläžã«150r.p.mã®æ¹æéåºŠã§æ¹æããŠæž
æ¿åæ£ãããåŸãããªã°ãªã·ãžã«ã€ãœã·ã¢ãã¬ãŒ
ã10gãã¯ãããã«ã 30mlãããªã溶液ãå ããŠ
50ã70âã®æž©åºŠã§æ¶æ©ç¡¬ååå¿ãè¡ãªããçç¶é
åäœãããªãåžçå€85gãåŸããExample 4 In the same manner as in Example 1, bisphenol-A
- Reaction of 19.0 g of diglycidyl ether, 34.8 g of ethylene glycol diglycidyl ether, 27.6 g of 4,4'-diaminodiphenylmethane and 16.2 g of hexamethylene diamine in the presence of 40 ml of chloroform and 20 g of dioctyl phthalate at a temperature of 28°C. A prepolymer solution was prepared, and this was suspended and dispersed in 800 ml of an aqueous medium containing 40 g of sodium chloride and 6.0 g of bentonite by stirring at a stirring speed of 150 rpm, followed by 10 g of triglycidyl isocyanurate and chloroform. Add a solution consisting of 30 ml
A crosslinking and curing reaction was carried out at a temperature of 50 to 70°C to obtain 85 g of an adsorbent made of a spherical polymer.
ãã®åžçå€ïŒmlãçšããŠã宿œäŸïŒãšåæ§ã®æ¹
æ³ã§çè¡æž
äžã®ããªã«ãã³ãã€ã³ãã·ã¢ãã³ã°ãª
ãŒã³ïŒICGïŒãããã¢ã¹ã«ããã¿ã¬ã€ã³ïŒBSRïŒ
ã®æ¯çªåžç詊éšãè¡ã€ãåŠãããªã«ãã³65ïŒ
ã
ICG62ïŒ
ãBSP61ïŒ
ã®ååžççãåŸããããæŽã«
é åéèã·ã€ã³ãæè¡ãæœããå®¶å
ãçšããè¡æ¶²
äœå€æœ
æµè©Šéšã«ãã€ãŠè¡æ¶²é©åæ§ãè¯å¥œãªããšã
èªããããã Using 2 ml of this adsorbent, bilirubin, indocyanine green (ICG), and promosulfophthalein (BSR) in bovine serum were detected in the same manner as in Example 1.
When a shaking adsorption test was conducted, bilirubin was 65%,
Adsorption rates of ICG 62% and BSP 61% were obtained. Furthermore, good blood compatibility was confirmed in an extracorporeal blood perfusion test using rabbits that had undergone carotid artery shunt surgery.
宿œäŸ ïŒ
宿œäŸïŒãšåæ§ã®æ¹æ³ã§ãããªã°ãªã·ãžã«ã€ãœ
ã·ã¢ãã¬ãŒã20gããšãã¬ã³ã°ãªã³ãŒã«ãžã°ãªã·
ãžã«ãšãŒãã«34.8gããããµã¡ãã¬ã³ãžã¢ãã³
31.0gåã³ã¹ãã¢ãªã«ã¢ãã³17.2gããã¯ãããã«
ã 40mlåã³ãã©ãã€ã³20gã®ååšäžã«ã28âã®æž©
床ã§åå¿ãããŠãã¬ããªããŒæº¶æ¶²ã調補ãããã
ãå¡©åãããªãŠã 40gããã³ããã€ã6.0gã嫿
ããæ°Žæ§åªäœ800mläžã«150r.p.mã®æ¹æéåºŠã§æ¹
æããŠæžæ¿åæ£ãããåŸãããªã°ãªã·ãžã«ã€ãœã·
ã¢ãã¬ãŒã10gãã¯ãããã«ã 30mlãããªã溶液
ãå ããŠ50ã70âã®æž©åºŠã§æ¶æ©åå¿ãè¡ããçç¶
éåäœãããªãåžçå€100gãåŸããExample 5 In the same manner as in Example 1, 20 g of triglycidyl isocyanurate, 34.8 g of ethylene glycol diglycidyl ether, and hexamethylene diamine were added.
A prepolymer solution was prepared by reacting 31.0 g of stearylamine and 17.2 g of stearylamine in the presence of 40 ml of chloroform and 20 g of paraffin at a temperature of 28° C., which was dissolved in 800 ml of an aqueous medium containing 40 g of sodium chloride and 6.0 g of bentonite. After suspension and dispersion by stirring at a stirring speed of 150 rpm, a solution consisting of 10 g of triglycidyl isocyanurate and 30 ml of chloroform is added, and a crosslinking reaction is carried out at a temperature of 50 to 70°C to form an adsorbent made of spherical polymers. 100g of the drug was obtained.
ãã®åžçå€ïŒmlãçšããŠã宿œäŸïŒãšåæ§ã®æ¹
æ³ã§ãçè¡æž
äžã®ããªã«ãã³ãã€ã³ãã·ã¢ãã³ã°
ãªãŒã³ïŒICGïŒãããã¢ã¹ã«ããã¿ã¬ã€ã³ïŒBSPïŒ
ã®æ¯çªåžç詊éšãè¡ããããªã«ãã³70ïŒ
ãICG68
ïŒ
ãçSP70ïŒ
ã®ååžççãåŸããããæ¬çºæã®
èçœçµåæ§ç©è³ªãããåžçããããšãèªããã
ãã Using 2 ml of this adsorbent, bilirubin, indocyanine green (ICG), and promosulfophthalein (BSP) in bovine serum were detected in the same manner as in Example 1.
A shaking adsorption test was conducted, and bilirubin 70%, ICG68
% and eyebrow SP70% were obtained. It was found that the protein-binding substance of the present invention was well adsorbed.
Claims (1)
æ°Žãšäžæ··åæ§ã®äžæŽ»æ§ææ©æº¶åªäžã«ãããŠ30âæª
æºã®æž©åºŠã§éä»å åå¿ããããæ¬¡ãã§å¿ èŠã«å¿ã
ãŠè©²å€äŸ¡ãšããã·ååç©ã远å ããããšã«ãã€ãŠ
åå¿ã«äœ¿çšãã該å€äŸ¡ãšããã·ååç©äžã®å šãšã
ãã·åºãåå¿ã«äœ¿çšãã該å€äŸ¡ã¢ãã³ååç©äžã®
ã¢ãã³åºåã³ã€ããåºã®ïŒåœéåœãåã¯è©²å€äŸ¡ã¢
ãã³ååç©äžã«ã€ããåºãå«ãŸãªãå Žåã«ã¯ã¢ã
ãåºïŒåœéåœã1.05ã1.70åœéã®ç¯å²ãšãªããã
ã«èª¿æŽãã忣å®å®å€ã嫿ããæ°Žæ§åªäœäžã«æž
æ¿åæ£ãããã30â以äžã®æž©åºŠã§æŽã«åå¿ãè¡ã
ããšã«ããæžæ¿ç²åãæ¶æ©ç¡¬åããããããšãã
ãªãåžçå€ã®è£œé æ¹æ³ã1 Polyvalent amine compound and polyvalent epoxy compound are subjected to a polyaddition reaction in an inert organic solvent immiscible with water at a temperature of less than 30°C, and then the polyvalent epoxy compound is added as necessary. Therefore, all the epoxy groups in the polyvalent epoxy compound used in the reaction are per equivalent of the amine groups and imino groups in the polyvalent amine compound used in the reaction, or the polyvalent amine compound does not contain imino groups. In case, the amount is adjusted to be in the range of 1.05 to 1.70 equivalents per equivalent of amino group, suspended and dispersed in an aqueous medium containing a dispersion stabilizer, and further reacted at a temperature of 30°C or higher. A method for producing an adsorbent comprising crosslinking and curing particles.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56167047A JPS5869817A (en) | 1981-10-21 | 1981-10-21 | Preparation of adsorbent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56167047A JPS5869817A (en) | 1981-10-21 | 1981-10-21 | Preparation of adsorbent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5869817A JPS5869817A (en) | 1983-04-26 |
| JPH0152027B2 true JPH0152027B2 (en) | 1989-11-07 |
Family
ID=15842401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56167047A Granted JPS5869817A (en) | 1981-10-21 | 1981-10-21 | Preparation of adsorbent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5869817A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3733658B2 (en) * | 1995-12-28 | 2006-01-11 | æ±ã¬æ ªåŒäŒç€Ÿ | β2 microglobulin removal, detection or measurement material and body fluid purification column using the same |
-
1981
- 1981-10-21 JP JP56167047A patent/JPS5869817A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5869817A (en) | 1983-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6037458A (en) | Adsorbent for serum amyloid protein | |
| Guo et al. | Hollow mesoporous carbon spheresâan excellent bilirubin adsorbent | |
| JP2001508775A (en) | Method and apparatus for reducing small organic compounds from blood products | |
| JPS6259124B2 (en) | ||
| JP2003523777A (en) | Batch device for the reduction of compounds from biological compositions containing cells and methods of use thereof | |
| US7408045B2 (en) | Adsorbent of high-mobility-group protein and body fluid-purification column | |
| EP0028937B1 (en) | Albumin-fixed resin, process for its production, method of using it to remove noxious substances from solutions containing them, and its use in removing noxious substances from blood | |
| JPS6241667A (en) | Adsorbing material for immunoglobrin and adsorbing apparatusequipped therewith | |
| CN103933947B (en) | For blood purification material removing rheumatoid factor and preparation method thereof | |
| JPH0152027B2 (en) | ||
| SK36293A3 (en) | Process for preparing optially active cyanohydrins with enzymes | |
| JPS639450A (en) | Body fluid component separating material and body fluid component separator equipped therewith | |
| JPS6333872B2 (en) | ||
| JP6911681B2 (en) | Method for purifying adsorbents and target substances | |
| JP4228498B2 (en) | Heparin adsorbent and method for removing heparin using the same | |
| US6309999B1 (en) | Process for the preparation of an immunoadsorbent matrix | |
| RU2029564C1 (en) | Adsorbent for extracting atherogenic lipoproteins from biological liquids | |
| JPH0738881B2 (en) | Container for removing activated complement components | |
| JPH0616842B2 (en) | Adsorbent for activated complement components | |
| JPH05285381A (en) | Low-specific gravity lipoprotein adsorptive material | |
| CN121287934A (en) | Covalent organic framework materials for loading boron drug compounds, their preparation methods and applications | |
| JPH0753177B2 (en) | Method for adsorption removal of β2-microglobulin | |
| JPS62244442A (en) | Low specific gravity lipoprotein adsorbing material and its preparation | |
| JP3181343B2 (en) | Method for producing adsorbent material for body fluid purification | |
| JP2730211B2 (en) | Adsorbent for anti-acetylcholine receptor antibody |